caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1841264645

Ron SmithM.D.

PRACTICEMAYO CLINICSee all providers at this practice →
Radiation OncologyRochester, MNI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Ron Smith's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
MAYO CLINIC HEALTH SYSTEM-SOUTHWEST MINNESOTA REGION92988
OWENS, DAVID19174
Mohammad Ranginwala
Medical Oncology · Mankato, MN
15140
Amrit Singh
Hematology-Oncology · Mankato, MN
14107
Stephan Thome
Medical Oncology · Mankato, MN
13110
William Morice
Pathology · Rochester, MN
12114
Peter Reichert
Diagnostic Radiology · Mankato, MN
1244
Jonathan Hard
Diagnostic Radiology · Mankato, MN
1152
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
845
Unique beneficiaries
—
Total services
2,735
Distinct HCPCS
20
Medicare payment
$545K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 119 Radiation Oncology providers in MN — top quintile (cohort median 986).
PRESCRIBING · PART D · 2024
Total Rx claims
32
Beneficiaries
—
Total drug cost
$235
Distinct drugs
2
Brand share
40.6%
Top prescribed drugs
Tamsulosin Hcl19 claims
Ondansetron13 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.